For the placebo arm participants were started on: 1 metformin, 2 dapagliflozin (Supplementary Table 4)
MRM now offers this remarkable amino acid in a liquid delivery system for optimal absorption
GIP activation improves insulin response after meals and appears to reduce nausea relative to GLP-1-only agents, the tirzepatide effect seen in the Body Pharm Tirzepatide 30 Pen
Kishimoto, A., Komiyama, M., Wada, H., Satoh-Asahara, N., Yamakage, H., Ajiro, Y., Aoyama, H., Katsuura, Y., Imaizumi, A., Hashimoto, T., Sunagawa, Y., Morimoto, T., Kanai, M., Kakeya, H., Hasegawa, K.: Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial